Mount Yale Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,236
| Closed | -$1.05M | – | 536 |
|
|
2022
Q4 | $1.05M | Sell |
9,236
-488
| -5% | -$55.5K | 0.12% | 176 |
|
|
2022
Q3 | $602K | Sell |
9,724
-494
| -5% | -$30.6K | 0.08% | 245 |
|
|
2022
Q2 | $815K | Sell |
10,218
-629
| -6% | -$50.2K | 0.1% | 197 |
|
|
2022
Q1 | $1.14M | Sell |
10,847
-1,108
| -9% | -$117K | 0.12% | 178 |
|
|
2021
Q4 | $1.29M | Sell |
11,955
-174
| -1% | -$18.7K | 0.13% | 166 |
|
|
2021
Q3 | $1.33M | Sell |
12,129
-146
| -1% | -$16K | 0.15% | 146 |
|
|
2021
Q2 | $1.15M | Sell |
12,275
-1,654
| -12% | -$155K | 0.14% | 157 |
|
|
2021
Q1 | $1.28M | Sell |
13,929
-591
| -4% | -$54.4K | 0.17% | 126 |
|
|
2020
Q4 | $1.06M | Sell |
14,520
-1,226
| -8% | -$89.7K | 0.15% | 157 |
|
|
2020
Q3 | $1.22M | Sell |
15,746
-1,888
| -11% | -$147K | 0.17% | 125 |
|
|
2020
Q2 | $980K | Buy |
17,634
+9,941
| +129% | +$552K | 0.18% | 127 |
|
|
2020
Q1 | $228K | Buy |
7,693
+1,273
| +20% | +$37.7K | 0.05% | 259 |
|
|
2019
Q4 | $221K | Sell |
6,420
-680
| -10% | -$23.4K | 0.04% | 303 |
|
|
2019
Q3 | $215K | Sell |
7,100
-729
| -9% | -$22.1K | 0.04% | 293 |
|
|
2019
Q2 | $207K | Buy |
+7,829
| New | +$207K | 0.04% | 289 |
|
|
2019
Q1 | – | Sell |
-10,501
| Closed | -$242K | – | 317 |
|
|
2018
Q4 | $242K | Sell |
10,501
-3,847
| -27% | -$88.7K | 0.05% | 278 |
|
|
2018
Q3 | $322K | Buy |
14,348
+6,399
| +81% | +$144K | 0.06% | 243 |
|
|
2018
Q2 | $132K | Buy |
7,949
+1,719
| +28% | +$28.5K | 0.03% | 383 |
|
|
2018
Q1 | $88K | Buy |
+6,230
| New | +$88K | 0.02% | 493 |
|